Hydrocephalus is a chronic condition characterised by the accumulation of excessive cerebrospinal fluid in the brain. Credit: Elif Bayraktar / Shutterstock.com.

Anuncia Medical has announced the first successful implantation of its recently launched second-generation ReFlow Mini Flusher device for patients with hydrocephalus in the US.

The procedure has been conducted at Intermountain Primary Children’s Hospital in Salt Lake City by neurosurgeon Samuel Cheshier.

Go deeper with GlobalData

Premium Insights

The gold standard of business intelligence.

Find out more

Related Company Profiles

View all

The patient in the procedure previously required 11 brain surgeries to address hydrocephalus, a chronic condition characterised by the accumulation of excessive cerebrospinal fluid (CSF) in the brain.

The device, which received approval from the US Food and Drug Administration (FDA), is intended for the treatment of patients with hydrocephalus or similar conditions.

Its reduced size and profile help better treat a wider range of hydrocephalus patients, spanning from infants to older adults.

See Also:

When utilised alongside any shunt system brand, the ReFlow Mini Flusher facilitates the flushing of the patient’s CSF back into the ventricular catheter for maintaining, restoring or increasing hydrocephalus shunt flow.

How well do you really know your competitors?

Access the most comprehensive Company Profiles on the market, powered by GlobalData. Save hours of research. Gain competitive edge.

Company Profile – free sample

Thank you!

Your download email will arrive shortly

Not ready to buy yet? Download a free sample

We are confident about the unique quality of our Company Profiles. However, we want you to make the most beneficial decision for your business, so we offer a free sample that you can download by submitting the below form

By GlobalData
Visit our Privacy Policy for more information about our services, how we may use, process and share your personal data, including information of your rights in respect of your personal data and how you can unsubscribe from future marketing communications. Our services are intended for corporate subscribers and you warrant that the email address submitted is your corporate email address.

Anuncia Medical sales and marketing new vice-president Mark Geiger said: “The ReFlow Mini Flusher developed off the ‘Gen 1’ platform, with a decade of work and recently published clinical data with four-plus years of follow-up, may profoundly impact hydrocephalus patients, by providing control and confidence, through noninvasive ventricular catheter flushing at home, to restore and maintain CSF flow.”

The first-generation ReFlow device has also been investigated in 11 clinical studies.